Several compounds, notably 18, 20, 21, 23, and 24, displayed activity towards the pancreatic cancer cell lines BxPC‐3, known to overexpress Mcl‐1, and MiaPaCa‐2, which overexpresses both Mcl‐1 and Bcl‐2. The gene discussed is BCL2; the disease is pancreatic neoplasm.